[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2011 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
10-Aug-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Jun-2011 [#2]
Profit Trend
QoQ- -5.05%
YoY- 22.24%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Revenue 1,786,980 1,520,981 1,537,593 1,563,526 1,541,312 1,378,348 1,336,309 21.35%
PBT 171,820 73,186 75,757 82,344 87,168 45,462 64,217 92.61%
Tax -55,576 -20,401 -21,620 -23,056 -24,772 -15,152 -21,201 90.00%
NP 116,244 52,785 54,137 59,288 62,396 30,310 43,016 93.89%
-
NP to SH 114,740 52,157 53,620 58,808 61,936 30,384 43,520 90.73%
-
Tax Rate 32.35% 27.88% 28.54% 28.00% 28.42% 33.33% 33.01% -
Total Cost 1,670,736 1,468,196 1,483,456 1,504,238 1,478,916 1,348,038 1,293,293 18.59%
-
Net Worth 474,161 514,273 464,307 451,381 437,661 421,524 424,715 7.61%
Dividend
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Div 35,297 35,304 - - - 10,698 67,041 -34.77%
Div Payout % 30.76% 67.69% - - - 35.21% 154.05% -
Equity
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Net Worth 474,161 514,273 464,307 451,381 437,661 421,524 424,715 7.61%
NOSH 117,657 117,682 106,983 106,962 107,007 106,985 106,981 6.54%
Ratio Analysis
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
NP Margin 6.51% 3.47% 3.52% 3.79% 4.05% 2.20% 3.22% -
ROE 24.20% 10.14% 11.55% 13.03% 14.15% 7.21% 10.25% -
Per Share
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
RPS 1,518.79 1,292.44 1,437.23 1,461.75 1,440.38 1,288.35 1,249.11 13.90%
EPS 97.52 44.32 50.12 54.98 57.88 28.40 40.68 79.02%
DPS 30.00 30.00 0.00 0.00 0.00 10.00 62.67 -38.77%
NAPS 4.03 4.37 4.34 4.22 4.09 3.94 3.97 1.00%
Adjusted Per Share Value based on latest NOSH - 106,994
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
RPS 123.99 105.53 106.68 108.48 106.94 95.64 92.72 21.35%
EPS 7.96 3.62 3.72 4.08 4.30 2.11 3.02 90.69%
DPS 2.45 2.45 0.00 0.00 0.00 0.74 4.65 -34.74%
NAPS 0.329 0.3568 0.3222 0.3132 0.3037 0.2925 0.2947 7.60%
Price Multiplier on Financial Quarter End Date
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Date 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 -
Price 5.90 5.36 5.90 5.90 5.73 5.31 4.98 -
P/RPS 0.39 0.41 0.41 0.40 0.40 0.41 0.40 -1.67%
P/EPS 6.05 12.09 11.77 10.73 9.90 18.70 12.24 -37.45%
EY 16.53 8.27 8.49 9.32 10.10 5.35 8.17 59.89%
DY 5.08 5.60 0.00 0.00 0.00 1.88 12.58 -45.33%
P/NAPS 1.46 1.23 1.36 1.40 1.40 1.35 1.25 10.89%
Price Multiplier on Announcement Date
31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 CAGR
Date 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 -
Price 5.90 5.90 5.90 5.90 5.05 5.35 4.92 -
P/RPS 0.39 0.46 0.41 0.40 0.35 0.42 0.39 0.00%
P/EPS 6.05 13.31 11.77 10.73 8.72 18.84 12.09 -36.94%
EY 16.53 7.51 8.49 9.32 11.46 5.31 8.27 58.60%
DY 5.08 5.08 0.00 0.00 0.00 1.87 12.74 -45.79%
P/NAPS 1.46 1.35 1.36 1.40 1.23 1.36 1.24 11.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment